The first clinical trials are slated to begin in the U.S. and Europe while others are stalled.
In a historic move, the Food and Drug Administration on Tuesday approved a pioneering gene therapy for a rare form of childhood blindness, the first such treatment cleared in the United States for an inherited disease.
Measuring a blood protein, apoB, might save more lives
Moderna this week started testing a personalized treatment that teaches the body how
to fight cancer.
A group of researchers at Columbia University’s School of Engineering and Applied Science have successfully developed the first functional vascularised lung scaffold, and it could dramatically change how lung disease is treated.
This is where awareness lives.
Patients with unexplained low blood counts and abnormally mutated cells who do not fit the diagnostic criteria for recognized blood cancers should be described as having clonal cytopenias of undetermined significance (CCUS), suggest University of California, San Diego School of Medicine researchers in a recent paper published in the journal Blood. The researchers found the condition surprisingly common in older patients with low blood counts.
The U.S. Food and Drug Administration approved Xuriden (uridine triacetate), the first FDA-approved treatment for patients with hereditary orotic aciduria. Hereditary orotic aciduria is a rare metabolic disorder, which has been reported in approximately 20 patients worldwide.
A dose of 3D printing could transform the way patients take their medications
A study at the American Society of Clinical Oncology suggests two cancer drugs can shrink tumors in nearly 60% of people
Pain-free device could be an alternative to needle pricks
Clinical trials show that a smartphone-linked artificial pancreas could help free patients with type 1 diabetes from needing regulate their bloo